Cargando…

Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer

OBJECTIVE: The aim of this study was to compare Conventional fractionated radiotherapy (CFRT) and Hypofractionated radiotherapy (HFRT) in terms of treatment outcomes, such as in 5-year loco-regional recurrence free survival, disease free survival, overall survival, and distant metastatic free surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tovanabutra, Chokaew, Katanyoo, Kanyarat, Uber, Pichet, Chomprasert, Kittisak, Sookauychai, Sitti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294031/
https://www.ncbi.nlm.nih.gov/pubmed/31983173
http://dx.doi.org/10.31557/APJCP.2020.21.1.119
_version_ 1783546400444776448
author Tovanabutra, Chokaew
Katanyoo, Kanyarat
Uber, Pichet
Chomprasert, Kittisak
Sookauychai, Sitti
author_facet Tovanabutra, Chokaew
Katanyoo, Kanyarat
Uber, Pichet
Chomprasert, Kittisak
Sookauychai, Sitti
author_sort Tovanabutra, Chokaew
collection PubMed
description OBJECTIVE: The aim of this study was to compare Conventional fractionated radiotherapy (CFRT) and Hypofractionated radiotherapy (HFRT) in terms of treatment outcomes, such as in 5-year loco-regional recurrence free survival, disease free survival, overall survival, and distant metastatic free survival rates as well as toxicity. MATERIALS AND METHODS: We retrospectively analyzed the data obtained from 462 breast cancer patients who received complete adjuvant radiotherapy treatment between January 2012 and December 2014. One hundred twenty eight patients received CFRT 2 Gy daily fractions at a total dose of 48-60 Gy (group 1), while 334 patients received HFRT 2.65-2.67 Gy daily for 15-19 fractions at a total dose of 39.7-47.8 Gy 9 (grup 2). Treatment outcome such as 5-year loco-regional recurrence free survival, disease free survival, overall survival, and distant metastatic free survival rates as well as toxicity were measured and compared between two groups. RESULTS: Median follow-up was 65.7 months (ranging from 45.1 to 95.2 months). Five-year loco-regional recurrence free survival rate was 96.1% in both CFRT and HFRT groups (p=0.993). Five-year disease-free survival rate of CFRT group was higher (68.8%), but this difference was not significant (HFRT =63.5%) (p=0.396). These were complied with 5-year overall survival rate (71.9% and 64.7%, p=0.385). Five-year distant metastatic free survival rate was 85.9% in CFRT group and 79.6% in HFRT group (p=0.169). No difference was observed between two groups in terms of toxicities, including changes in chest wall appearance, skin fib rosis, brachial plexopathy, arm edema, pulmonary fibrosis, and cardiovascular events. CONCLUSION: The treatment outcomes of hypofractionated radiotherapy in the postmastectomy breast cancer patients is comparable to the outcomes of conventional treatment at the Chonburi Cancer Hospital as previously reported from other studies, and HFRT can be implemented in resource-limited settings.
format Online
Article
Text
id pubmed-7294031
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-72940312020-06-29 Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer Tovanabutra, Chokaew Katanyoo, Kanyarat Uber, Pichet Chomprasert, Kittisak Sookauychai, Sitti Asian Pac J Cancer Prev Research Article OBJECTIVE: The aim of this study was to compare Conventional fractionated radiotherapy (CFRT) and Hypofractionated radiotherapy (HFRT) in terms of treatment outcomes, such as in 5-year loco-regional recurrence free survival, disease free survival, overall survival, and distant metastatic free survival rates as well as toxicity. MATERIALS AND METHODS: We retrospectively analyzed the data obtained from 462 breast cancer patients who received complete adjuvant radiotherapy treatment between January 2012 and December 2014. One hundred twenty eight patients received CFRT 2 Gy daily fractions at a total dose of 48-60 Gy (group 1), while 334 patients received HFRT 2.65-2.67 Gy daily for 15-19 fractions at a total dose of 39.7-47.8 Gy 9 (grup 2). Treatment outcome such as 5-year loco-regional recurrence free survival, disease free survival, overall survival, and distant metastatic free survival rates as well as toxicity were measured and compared between two groups. RESULTS: Median follow-up was 65.7 months (ranging from 45.1 to 95.2 months). Five-year loco-regional recurrence free survival rate was 96.1% in both CFRT and HFRT groups (p=0.993). Five-year disease-free survival rate of CFRT group was higher (68.8%), but this difference was not significant (HFRT =63.5%) (p=0.396). These were complied with 5-year overall survival rate (71.9% and 64.7%, p=0.385). Five-year distant metastatic free survival rate was 85.9% in CFRT group and 79.6% in HFRT group (p=0.169). No difference was observed between two groups in terms of toxicities, including changes in chest wall appearance, skin fib rosis, brachial plexopathy, arm edema, pulmonary fibrosis, and cardiovascular events. CONCLUSION: The treatment outcomes of hypofractionated radiotherapy in the postmastectomy breast cancer patients is comparable to the outcomes of conventional treatment at the Chonburi Cancer Hospital as previously reported from other studies, and HFRT can be implemented in resource-limited settings. West Asia Organization for Cancer Prevention 2020 /pmc/articles/PMC7294031/ /pubmed/31983173 http://dx.doi.org/10.31557/APJCP.2020.21.1.119 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tovanabutra, Chokaew
Katanyoo, Kanyarat
Uber, Pichet
Chomprasert, Kittisak
Sookauychai, Sitti
Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
title Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
title_full Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
title_fullStr Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
title_full_unstemmed Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
title_short Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
title_sort comparison of treatment outcome between hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294031/
https://www.ncbi.nlm.nih.gov/pubmed/31983173
http://dx.doi.org/10.31557/APJCP.2020.21.1.119
work_keys_str_mv AT tovanabutrachokaew comparisonoftreatmentoutcomebetweenhypofractionatedradiotherapyandconventionalradiotherapyinpostmastectomybreastcancer
AT katanyookanyarat comparisonoftreatmentoutcomebetweenhypofractionatedradiotherapyandconventionalradiotherapyinpostmastectomybreastcancer
AT uberpichet comparisonoftreatmentoutcomebetweenhypofractionatedradiotherapyandconventionalradiotherapyinpostmastectomybreastcancer
AT chomprasertkittisak comparisonoftreatmentoutcomebetweenhypofractionatedradiotherapyandconventionalradiotherapyinpostmastectomybreastcancer
AT sookauychaisitti comparisonoftreatmentoutcomebetweenhypofractionatedradiotherapyandconventionalradiotherapyinpostmastectomybreastcancer